Julius Youngner Health Service, National Institutes of Health Cancer Institute before joining the Salk team responsible for polio vaccine. As a member of the Jonas Salk research team, Youngner contributed in the development of polio vaccine, including techniques for large scale production of poliovirus and the rapid color test measurement of polio virus in living tissue. He is considered "one of the seminal figures in contemporary virology and it's been that way for more than 50 years" by Arthur S. Levine, senior vice chancellor for the health sciences at University of Pittsburgh. Research by Youngner and colleague Samuel Salvin was also responsible
Jonas Salk talks continually about getting out of the limelight and back to his laboratory ... because of his genuine distaste for publicity, which he believes is inappropriate for a scientist." During a 1980 interview, 25 years later, he said, "It's as if I've been a public property ever since, having to respond to external, as well as internal, impulses. ... It's brought me enormous gratification, opened many opportunities, but at the same time placed many burdens on me. It altered my career, my relationships with colleagues; I am a public figure, no longer one of them." "If Salk the scientist sounds